Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study-Reference-Cited by-同舟云学术

Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study

Published:2015-09-23 Issue:2 Volume:118 Page:258-263
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Herden Jan¹^ORCID,Wille Sebastian¹,Weissbach Lothar²

Affiliation:

1. Department of Urology; University Hospital Cologne; Cologne Germany

2. Foundation of Men's Health; Berlin Germany

Funder

Gazprom Germania

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13308/fullpdf

Reference30 articles.

1. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era;Jones;Prostate Cancer Prostatic Dis,2009

2. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients;Zigeuner;Urology,2003

3. Adenocarcinoma of the prostate in Iceland. a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987;Jonsson;Scand J Urol Nephrol,2006

4. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors;Robinson;Scand J Urol Nephrol,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer;World Journal of Urology;2024-04-28

2. Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate;PLOS ONE;2023-02-02

3. Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands;Radiotherapy and Oncology;2022-12

4. Predictors of Unfavorable Pathology in Patients with Incidental (pT1a–T1b) Prostate Cancer;European Urology Focus;2022-11

5. Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate;Cancers;2022-01-12